Comparison
SS-31 + MOTS-c vs SS-31 (elamipretide)
Side-by-side attributes from our library comparison data. Read each peptide leaf for dosing math, regulatory status, and citations.
SS-31 + MOTS-c vs. SS-31 (elamipretide)
| Attribute | SS-31 + MOTS-c | SS-31 (elamipretide) |
|---|---|---|
| Identity | Elamipretide + MOTS-c blend | Elamipretide alone |
| FDA | Not an approved combination | Forzinity™ accelerated approval (Barth, Sep 2025) |
| Job | Vendor mitochondrial stack | Labeled Barth product or research vial |
Verdict: The stack is not Forzinity. Elamipretide’s approval is a single-agent, single-indication story.